Lipocine (LPCN) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.59
-0.51
-0.43
-0.35

Details

Expected EPS
-0.485
Actual EPS
-0.54
Surprise EPS
-0.06
Surprise Percent
-11.34%

Description

⁨Lipocine⁩ (⁦LPCN⁩) has reported earnings of ⁦-0.54⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts